medigraphic.com
ISSN 1560-4381 (Print)

2022, Number 1

<< Back Next >>

Correo Científico Médico 2022; 26 (1)

Long-acting reversible contraception in millennial generation: systematic review

Naranjo LIE, Naranjo CAA, Serrano GNB, Bermúdez GAJ

Language: Spanish
References: 29
Page: 31-46
PDF size: 301.68 Kb.


ABSTRACT

Introduction: The millennial generation comprises those who were born between 1980 and 2000; they are identified as young entrepreneurs, with high levels of education and job qualifications, whose interest in sexual and reproductive health issues favors a greater adherence to the use of long-acting reversible contraception (LARC).
Objective: To determine whether long-acting reversible contraception is an effective and safe option for the millennial generation.
Method: A systematic review was carried out, with the methodology proposed by Arksey and O'Malley of selected scientific articles in English and Spanish, obtained from the following databases: PubMed (https://pubmed.ncbi.nlm.nih.gov), Cochrane Library (https://www.cochranelibrary.com), Scientific Electronic Library Online (SciELO) (https://scielo.org/es) and Google Scholar (https://scholar.google.com.cu). The main descriptor used was "long-acting reversible contraception" and its Spanish equivalent "anticoncepción reversible de larga duración" taken from the page Descriptores en Ciencias de la Salud (DeCS) at: https://decs.bvsalud.org/es.
Results: The articles analyzed have an observational and experimental character in correspondence with the topic of study and respond to the contraceptive needs of the millennial population. They recognize LARC as the best contraceptive option due to the safety and efficacy of the method, and its high adherence meets the needs of this population group. However, they must overcome obstacles to its generalization because of lack of information, costs and fears of its possible adverse effects.
Conclusions: Millennial women have a more stressful rhythm of life that leads them to make decisions that appear when facing the need to use LARC, safe and independent of the actions of the users.


REFERENCES

  1. Caetano C, Peers T, Papadopoulos L, Wiggers K, Engler Y, Grant H. Millennials and contraception: ¿why do they forget? An international survey exploring the impact of lifestyles and stress levels on adherence to a daily contraceptive regimen. Eur J Contracept Reprod Health Care. 2019[citado 25/08/2020];24(1):30-38.Disponible en:https://www.tandfonline.com/doi/full/10.1080/13625187.2018.1563065

  2. Jones RP, Cox D. How race and religion shape millennial attitudes on sexuality and reproductive health. Washington D.C: Public Religion Research Institute (PRRI).2015[citado 25/08/2020]. Disponible en:https://www.prri.org/wp-content/uploads/2015/03/PRRI-Millennials-Web-FINAL.pdf

  3. Gutiérrez Ramos M. Los métodos reversibles de larga duración (LARC), una real opción anticonceptiva en el Perú. Rev Peru Ginecol Obstet. 2017[citado 25/08/2020];63(1):83-88. Disponible en:http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2304-51322017000100011&lng=es

  4. Kaitz M, Mankuta D, Mankuta L. Long-acting reversible contraception: Aroute to reproductive justice or injustice. Infant Ment Health J. 2019[citado 25/08/2020];40(5):673-689.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972575/

  5. Martín Perpiñán C. Anticoncepción en adolescentes: Educación sexual y asistencia adecuada. Rev Esp Endocrinol Pediatr.2016 [citado 05/05/2020];7(2):19-22.Disponible en: https://www.endocrinologiapediatrica.org/modules.php?name=articulos&idarticulo=378&idlangart=EN

  6. Fonseca Villanea C. Dispositivos intrauterinos en adolescentes. Rev Méd Siner. 2017[citado 25/01/2021];2(4):3-7.Disponible en:https://www.medigraphic.com/pdfs/sinergia/rms-2017/rms174a.pdf

  7. Brito M, Costa AR, Pacheco A, Rebelo C, Castro MG, Martins I, et al. Tendências e perceções dos Ginecologistas Portugueses sobre contraceção hormonal intrauterina: o estudo DIOGIN. Acta Obstet Ginecol Port. 2020[citado 28/04/2021]; 14(2): 74-82. Disponible en:http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302020000200004&lng=pt

  8. Peláez Mendoza J. El uso de métodos anticonceptivos en la adolescencia. Rev Cubana Obstet Ginecol. 2016 [citado28/08/2021];42(1).Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2016000100011&lng=es

  9. OMS. Recomendaciones sobre prácticas seleccionadas para el uso de anticonceptivos. Ginebra: OMS; 2018[citado 18/02/2020]. Disponible en:https://www.who.int/reproductivehealth/publications/family_planning/SPR-3/es/

  10. Vilela Borges AL, Simão Araújo K, Santos OA dos, Gonçalves RFS, Fujimori E, Divino E do A, et al. Conocimiento e interés en el uso del dispositivo intrauterino entre mujeres usuarias de unidades salud. Rev Latino Am Enfermagem. 2020[citado 02/08/2020]; 28:3232. Disponible en: https://www.scielo.br/j/rlae/a/MBdtsctXQTtVZhMX6rmyQzB/?lang=es

  11. Vargas Mora S, Estrada Rodríguez C. Anticoncepción con dispositivo intrauterino. Rev Med Costa Rica Centroamer. 2013[citado 25/08/2020];LXXX(606):227-231.Disponible en:https://www.binasss.sa.cr/revistas/rmcc/606/art22.pdf

  12. Davis DN, Lemani C, Kamtuwanje N, Phiri B, Masepuka P, Kuchawo S, et al. Task shifting levonorgestrel implant insertion to community midwife assistants in Malawi: results from a non-inferiority evaluation. Contracept Reprod Med. 2018[citado 28/04/2021];3:24.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211513/

  13. Calixto Morales DP, Ospina Díaz JM, Manrique Abril FG. Retiro temprano del implante subdérmico con etonogestrel en usuarias de un programa de anticoncepción de Tunja - Boyacá, Colombia. Univ Salud. 2015[citado 25/07/2020];17(2):224-232. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S0124-71072015000200008&lng=en&nrm=iso&tlng=es

  14. Fernández Sánchez H, King K, Enríquez Hernández CB. Revisiones sistemáticas exploratorias como metodología para la síntesis del conocimiento científico. Enferm Univ. 2020 [citado 17/08/2020]; 17(1):87-94. Disponible en:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-70632020000100087&lng=es&nrm=iso&tlng=es

  15. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012[citado 15/08/2020]; 366 (21): 1998‐2007.Disponible en: https://www.nejm.org/doi/full/10.1056/nejmoa1110855

  16. Hubacher D, Spector H, Monteith C, Chen PL. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction. Contraception. 2018[citado 25/07/2021]; 97(6):524‐532. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331179/

  17. Kungu W, Khasakhala A, Agwanda A. Use of long-acting reversible contraception among adolescents and young women in Kenya. PLoS One. 2020[citado 25/07/2021]; 15(11):0241506. Disponible en: https://doi.org/10.1371/journal.pone.0241506

  18. Divisón Garrote JA, Escobar Cervantes C, Seguí Díaz M. Provisión gratuita de anticonceptivos de larga duración y embarazos en adolescentes. Semergen. 2015[citado 08/04/2020]; 41(3):172-173. Disponible en: https://www.elsevier.es/es-revista-medicina-familia-semergen-40-articulo-provision-gratuita-anticonceptivos-larga-duracion-S113835931400478X

  19. von Hoveling Schindler A, Larrea Schindler E, Norambuena Narváez C, Carrasco Leal L. Prevención del Embarazo Reiterado en Adolescentes: una Experiencia Clínica Exitosa. Rev Chil Obstet Ginecol. 2020[citado 25/04/2021]; 85(6):631-640. Disponible en:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262020000600631&lng=es

  20. Richards MJ, Coleman Minahan K, Sheeder J. Long-Acting Reversible Contraceptive Attitudes and Acceptability in Adolescents and Young Adults: A Key to Patient-Centered Contraceptive Counseling. J Pediatr Adolesc Gynecol. 2020[citado 06/06/2020];33(6):673-680.Disponible en: https://www.em-consulte.com/article/1413845/long-acting-reversible-contraceptive-attitudes-and

  21. 21.Saloranta TH, Gyllenberg FK, But A, Gissler M, Laine MK, Heikinheimo O. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons. Am J Obstet Gynecol. 2020[citado 27/02/2020]; 223(6):1-17. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0002937820306414

  22. Paul R, Huysman BC, Maddipati R, Madden T. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice. Am J Obstet Gynecol. 2020[citado 25/07/2021]; 222(4 Suppl):884.1-884.9.Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781163/pdf/nihms-1546515.pdf

  23. 23.George JL, Hussein N, Goba GK, Hussain NA. What Does He Think? Male Knowledge and Attitudes of Long Acting Reversible Contraception (LARC). J Pediatr Adolesc Gynecol. 2021[citado 20/12/2021];34(6):821-824.Disponible en:https://www.jpagonline.org/article/S1083-3188(21)00261-8/fulltext

  24. Emtell Iwarsson K, Envall N, Bizjak I, Bring J, Kopp Kallner H, Gemzell Danielsson K. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial). BJOG. 2021[citado 25/09/2021];128(9):1546-1554.Disponible en:https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.16754

  25. Black KI, McGeechan K, Watson CJ, Lucke J, Taft A, McNamee K, et al. Women's satisfaction with and ongoing use of hormonal long-acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd). Aust N Z J Obstet Gynaecol. 2021[citado 25/09/2021];61(3):448-453.Disponible en: https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/ajo.13319

  26. Leroy Melamed M, Zhao Q, Belmonte MA, Archer J, Peipert JF. Contraceptive Preference, Continuation Rates, and Unintended Pregnancies in Patients with Comorbidities: A Prospective Cohort Study. J Womens Health (Larchmt). 2021[citado 25/11/2021];30(10):1469-1475. Disponible en: https://www.liebertpub.com/doi/pdf/10.1089/jwh.2020.8536

  27. Hubacher D, Spector H, Monteith C, Chen PL, Hart C. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. Am J Obstet Gynecol. 2017[citado 15/10/2021]; 216(2):101-109. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479328/pdf/nihms-814290.pdf

  28. Bahamondes L, Villarroel C, Frías Guzmán N, Oizerovich S, Velázquez Ramírez N, Monteiro I. The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations. Hum Reprod Open. 2018[citado 11/07/2020]; 2018(1). Disponible en: https://academic.oup.com/hropen/article/2018/1/hox030/4822170

  29. España: Ministerio de Sanidad, Consumo y Bienestar Social. Guía de Práctica Clínica de Anticoncepción Hormonal e Intrauterin. España: Ministerio de Sanidad, Consumo Y Bienestar Social; 2019[citado 15/07/2020].Disponible en:https://portal.guiasalud.es/wp-content/uploads/2019/06/gpc_585_anticoncepcion_iacs_compl.pdf




2020     |     www.medigraphic.com